Clinical Trials Sponsored by Jason B Luoma
Total 1 results
-
Jason B LuomaMultidisciplinary Association for Psychedelic Studies; Portland Psychotherapy... and other collaboratorsActive, not recruiting
Sponsors and Collaborators
- National Institute of Cardiovascular Diseases, Bangladesh
- Bassam Abdulkarim
- Dr Philippe METELLUS
- Centro Universitário Franciscano
- Hospitales Universitarios Virgen del Rocío
- the people hospital of Linzhi
- ECMC
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- Sahachat Aueyingsak
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- AlpinARC
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Åke Wibergs Stiftelse
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Sublimity Therapeutics Holdco Limited
- Etan Orgel
- Glasgow Western Infirmary
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Daniela Pacella - University of Naples Federico II, Naples
- View Full List
Medical Conditions
- Hyperprolinemia
- Value-Based Health Insurance
- Degenerative Spondylolisthesis G1
- Interviews
- Pancreaticoduodenectomy
- Orthopaedic Disorders
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Transitional Cell Carcinoma of Renal Pelvis
- Legal History
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Progression to PD-1 Antibody
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Ability to Swim 100m Independent Freestyle
- Panniculectomy
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Genetic Risk Factor
- Eosinophil Blood Count
- Initiation of Depo-Provera (DMPA)
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Patients With Leptomeningeal Disease
- View Full List
Drug Interventions
- UFUR and Iressa
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- 0% N2O
- Injectable Insulin
- Prasugrel
- HBM4003 and Triprilimab
- Cefuroxime 750mg oral
- Epirubicin hydrochloride
- 6% hetastarch
- Erythropoietin
- Nimotuzumab
- IV rtPA (intravenous recombinant plasminogen activator)
- Mepivacaine
- Omeprazole 20mg
- Gefitinib
- Antibiotic treatment
- 5-Fluoro-uracil
- ASP8062
- Paliperidone palmitate
- Metoclopramide + dexamethasone
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Egypt
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mali
- Contract Research Organizations in Peru
- Contract Research Organizations in Russia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Uzbekistan
- CRO list by country